Clinical utility of guanfacine extended release in the treatment of ADHD in children and adolescents

Clinical utility of guanfacine extended release in the treatment of ADHD in children and adolescents

Nicholas T Bello Department of Animal Sciences, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA Abstract: Attention deficit hyperactivity disorder (ADHD) is the most common psychiatric illness in children and adolescents. Several stimulant medications, such as methylphenidate a...

Full description

Bibliographic Details
Main Author:	Bello NT
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-06-01
Series:	Patient Preference and Adherence
Online Access:	http://www.dovepress.com/clinical-utility-of-guanfacine-extended-release-in-the-treatment-of-ad-peer-reviewed-article-PPA

Similar Items

Profile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorder
by: Martinez-Raga J, et al.
Published: (2015-05-01)

A retrospective medical chart review of clinical outcomes in children and adolescents with attention-deficit/hyperactivity disorder treated with guanfacine extended-release in routine Canadian clinical practice
by: Judy van Stralen, et al.
Published: (2021-10-01)

Guanfacine monotherapy for ADHD/ASD comorbid with Tourette syndrome: a case report
by: Kosuke Okazaki, et al.
Published: (2019-03-01)

Guanfacine treatment improves ADHD phenotypes of impulsivity and hyperactivity in a neurofibromatosis type 1 mouse model
by: J. L. Lukkes, et al.
Published: (2020-01-01)

Noradrenergic Add-on Therapy with Extended-Release Guanfacine in Alzheimer’s Disease (NorAD): study protocol for a randomised clinical trial and COVID-19 amendments
by: Karen Hoang, et al.
Published: (2022-08-01)

Guanfacine Treatment in a Patient with Intravenous Buprenorphine/Naloxone Misuse
by: Sercan Karabulut
Published: (2024-01-01)

Guanfacine as an effective drug for the treatment of tic disorder. Case report
by: P. Del Sol Calderon, et al.
Published: (2021-04-01)

Effect of Enteral Guanfacine on Dexmedetomidine Use in the ICU
by: Megan B. Fetters, PharmD, et al.
Published: (2022-11-01)

Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study
by: Akira Iwanami, et al.
Published: (2020-12-01)

Lisdexamfetamine in combination with guanfacine as an effective treatment in the management of behavioral disturbances in patients with Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD). Case report
by: P. Del Sol Calderon, et al.
Published: (2023-03-01)

Assessing Palatability of a New Amphetamine Extended-Release Tablet Formulation for the Treatment of ADHD
by: Pardo A, et al.
Published: (2021-07-01)

The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD)
by: Sagvolden Terje
Published: (2006-12-01)

An adolescent boy with kleptomania and attention‐deficit hyperactivity disorder treated with methylphenidate and guanfacine: A case report
by: Kensuke Miyazaki, et al.
Published: (2023-12-01)

Chronic Administrations of Guanfacine on Mesocortical Catecholaminergic and Thalamocortical Glutamatergic Transmissions
by: Kouji Fukuyama, et al.
Published: (2021-04-01)

Gender-Related Clinical Characteristics in Children and Adolescents with ADHD
by: Pietro De Rossi, et al.
Published: (2022-01-01)

Age-related clinical characteristics of children and adolescents with ADHD
by: Pietro De Rossi, et al.
Published: (2023-01-01)

Efficacy and safety of guanfacine extended‐release in Japanese adults with attention‐deficit/hyperactivity disorder: Exploratory post hoc subgroup analyses of a randomized, double‐blind, placebo‐controlled study
by: Noriyuki Naya, et al.
Published: (2021-03-01)

The Utility of I-Poems to Explore Subjective Well-Being in Children and Adolescents with ADHD
by: Andrea Marisa Nicolaou, et al.
Published: (2024-03-01)

Combined Use of Guanfacine and N-Acetylcysteine for the Treatment of Cognitive Deficits After Traumatic Brain Injury
by: Siddharth Khasnavis, et al.
Published: (2024-03-01)

Pediatric clonidine and guanfacine poisoning: a single-center retrospective review
by: Kevin Baumgartner, et al.
Published: (2021-11-01)

Ten Years (2011–2021) of the Italian Lombardy ADHD Register for the Diagnosis and Treatment of Children and Adolescents with ADHD
by: Maurizio Bonati, et al.
Published: (2021-07-01)

Noradrenergic Modulation of Learned and Innate Behaviors in Dopamine Transporter Knockout Rats by Guanfacine
by: Anna Volnova, et al.
Published: (2023-01-01)

Psychostimulants Modafinil, Atomoxetine and Guanfacine Impair Bone Cell Differentiation and MSC Migration
by: Nele Wagener, et al.
Published: (2022-09-01)

Guanfacine for irritability, impulsivity, and agitation in elderly patients: A report of two cases
by: Takafumi Miyoshi, et al.
Published: (2022-06-01)

White matter microstructure in children and adolescents with ADHD
by: Michael Connaughton, et al.
Published: (2022-01-01)

Variability of response to pharmacotherapy of naltrexone and guanfacin in patients with opioid dependence syndrome: pharmacogenetic aspect
by: V. Ya Palatkin, et al.
Published: (2019-12-01)

ADHD IN ADOLESCENTS
by: José Humberto Ayala Ibarra, et al.
Published: (2013-09-01)

Neurofeedback for the treatment of children and adolescents with ADHD: a randomized and controlled clinical trial using parental reports
by: Duric Nezla S, et al.
Published: (2012-08-01)

New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children
by: Diana Domnitei, et al.
Published: (2010-05-01)

Clinical utility of valsartan in the treatment of hypertension in children and adolescents
by: Rossana Baracco, et al.
Published: (2011-03-01)

Clinical utility of etanercept in the treatment of arthritides in children and adolescents
by: Dore RK
Published: (2014-03-01)

The Role of Iron and Zinc in the Treatment of ADHD among Children and Adolescents: A Systematic Review of Randomized Clinical Trials
by: Roser Granero, et al.
Published: (2021-11-01)

Methylphenidate Use for Emotional Dysregulation in Children and Adolescents with ADHD and ADHD and ASD: A Naturalistic Study
by: Patrizia Ventura, et al.
Published: (2022-05-01)

Clinical utility and consumer considerations for the use of once-daily nevirapine extended release for HIV infection treatment
by: Pefura Yone EW, et al.
Published: (2012-12-01)

Baseline values from the electrocardiograms of children and adolescents with ADHD
by: Zhang Shuyu, et al.
Published: (2007-09-01)

Group cognitive behavioral therapy for children and adolescents with ADHD
by: Luzia Flavia Coelho, et al.
Published: (2017-05-01)

Clinical utility of raltegravir for the treatment of HIV infection in children and adolescents
by: Nuttall J, et al.
Published: (2013-08-01)

Herbal medicines in the treatment of children and adolescents with attention-deficit/hyperactivity disorder (ADHD): An updated systematic review of clinical trials
by: Haide Golsorkhi, et al.
Published: (2023-07-01)

Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
by: Rubin Richard, et al.
Published: (2009-12-01)

Methylphenidate treatment in an analgesic dependent adolescent with ADHD (eng)
by: Ayşegül Yolga Tahiroğlu, et al.
Published: (2021-12-01)